Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
The clinical study evaluates in an open-label, crossover design the comparative efficacy and
safety of intranasal oxytocin and autologous umbilical cord blood for improving the
functioning of children with autistic spectrum disorder